TRANSCODE THERAPEUTICS, INC. Long-term Debt, Gross
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Long-term Debt, Gross of $2.24 million as of 2021-07-13, per its 10-K filed 2022-03-31.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2022-03-31
- 2021-07-13: Long-term Debt, Gross $2.24M.
- 2021-06-30: Long-term Debt, Gross $2.24M.
- 2020-12-31: Long-term Debt, Gross $2.24M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2021-07-13 | $2.24M 10-K · filed 2022-03-31 |
| 2021-06-30 | $2.24M 10-Q · filed 2021-08-23 |
| 2020-12-31 | $2.24M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |